Ultromics
About
EchoGo uses ground-breaking machine learning and patented artificial intelligence to more accurately
diagnose Cardiovascular Diseases earlier in the care pathway. It enables physicians everywhere to use echocardiography – the least invasive and most accessible cardiac imaging modality –
to diagnose heart failure and coronary artery disease earlier, faster, and in more people.
Key Facts
Series B in 2021, 100 people, 5 years old
Successes in UK/NHS
£2.7M funding via the NHS AI award Implemented in 20 sites in the UK
Part of our AI offer
Learn more →Organisation details
Website
www.ultromics.com ↗Markets already exporting to
USA, UK
Desired Markets
Europe, Asia
Desired customer types
Hospitals, Primary Care, Health Systems
Organisation categories
Specialism
Specialised diagnostics
AI Services
Diagnostics & Decision Support